Zogenix, Inc.

( )
ZGNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 5.32%76.066.2%$205.22m
VRXValeant Pharmaceuticals International, Inc. -10.38%18.0414.1%$106.15m
CTLTCatalent, Inc. -0.03%88.162.2%$89.17m
JAZZJazz Pharmaceuticals Plc -0.78%126.082.4%$76.67m
BHCBausch Health Cos., Inc. -10.38%18.040.0%$75.32m
TNXPTonix Pharmaceuticals Holding Corp. -2.59%1.130.5%$56.03m
PRGOPerrigo Co. Plc -0.44%50.236.8%$45.26m
GWPHGW Pharmaceuticals Plc 2.04%111.606.2%$43.25m
ARGXargenx SE 0.00%230.760.0%$42.63m
ICLRICON plc 0.30%189.914.3%$41.81m
PCRXPacira Biosciences, Inc. 0.38%58.3510.3%$39.85m
AMRNAmarin Corp. Plc 0.00%7.001.5%$39.83m
ICPTIntercept Pharmaceuticals, Inc. 1.54%49.5016.8%$39.17m
MYOKMyoKardia, Inc. 3.12%103.401.8%$38.76m
VRNAVerona Pharma Plc 4.09%8.150.0%$38.12m

Company Profile

Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.